Literature DB >> 10441743

Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes.

B Hendrich1, C Abbott, H McQueen, D Chambers, S Cross, A Bird.   

Abstract

DNA methylation is essential for murine development and is implicated in the control of gene expression. MeCP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of mammalian, nuclear proteins related by the presence in each of an amino acid motif called the methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MeCP2, MBD1 and MBD2 can also repress transcription. We describe the genomic structure and chromosomal localization of the human and murine Mbd1, Mbd2, Mbd3, and Mbd4 genes. We find that the highly similar MBD2 and MBD3 proteins are encoded by genes that map to different chromosomes in humans and mice but show a similar genomic structure. The Mbd1 and Mbd2 genes, in contrast, map together to murine and human Chromosomes (Chrs)18. The Mbd3 and Mbd4 genes map to murine Chrs 10 and 6, respectively, while the human MBD3 and MBD4 genes map to Chrs 19 and 3, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441743     DOI: 10.1007/s003359901112

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  34 in total

1.  Active repression of methylated genes by the chromosomal protein MBD1.

Authors:  H H Ng; P Jeppesen; A Bird
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Methylation-dependent silencing at the H19 imprinting control region by MeCP2.

Authors:  Robert A Drewell; Carolyn J Goddard; Jean O Thomas; M Azim Surani
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

3.  Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development.

Authors:  B Hendrich; J Guy; B Ramsahoye; V A Wilson; A Bird
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

4.  Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1.

Authors:  Dan Zhu; Stephen B Hunter; Paula M Vertino; Erwin G Van Meir
Journal:  Cancer Res       Date:  2011-07-01       Impact factor: 12.701

5.  Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation.

Authors:  Edmund Wong; Kan Yang; Mari Kuraguchi; Uwe Werling; Elena Avdievich; Kunhua Fan; Melissa Fazzari; Bo Jin; Anthony M C Brown; Martin Lipkin; Winfried Edelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

6.  Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.

Authors:  Kalpana Ghoshal; Jharna Datta; Sarmila Majumder; Shoumei Bai; Xiaocheng Dong; Mark Parthun; Samson T Jacob
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

7.  Eyes on DNA methylation: current evidence for DNA methylation in ocular development and disease.

Authors:  Deborah C Otteson
Journal:  J Ocul Biol Dis Infor       Date:  2012-03-29

Review 8.  Molecular targets of epigenetic regulation and effectors of environmental influences.

Authors:  Supratim Choudhuri; Yue Cui; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-08       Impact factor: 4.219

9.  A complex interaction of imprinted and maternal-effect genes modifies sex determination in Odd Sex (Ods) mice.

Authors:  Christophe Poirier; Yangjun Qin; Carolyn P Adams; Yanett Anaya; Jonathan B Singer; Annie E Hill; Eric S Lander; Joseph H Nadeau; Colin E Bishop
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

10.  Cause and consequences of genetic and epigenetic alterations in human cancer.

Authors:  B Sadikovic; K Al-Romaih; J A Squire; M Zielenska
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.